Referred Tests
| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing. | |
Test ID: IFG23
Intact Fibroblast Growth Factor 23, Serum
Useful For 
Suggests clinical disorders or settings where the test may be helpful
Diagnosing and monitoring tumor induced osteomalacia
Diagnosing X-linked hypophosphatemia or autosomal dominant hypophosphatemic rickets
Diagnosing familial tumoral calcinosis with hyperphosphatemia
Highlights
Fibroblast growth factor 23 (FGF23) is a major regulator of phosphate homeostasis.
FGF23 measurements are useful in the differential diagnosis of hypophosphatemic diseases.
Intact FGF23 is elevated in patients with tumor induced osteomalacia (TIO) or X-linked hypophosphatemia (XLH).
Method Name A short description of the method used to perform the test
Chemiluminescence Based Quantitative Sandwich Immunoassay.
NY State Available Indicates the status of NY State approval and if the test is orderable for NY State clients.
Yes
Reporting Name Lists a shorter or abbreviated version of the Published Name for a test
Intact Fibroblast Growth Factor 23
Aliases Lists additional common names for a test, as an aid in searching
FGF23
Intact-FGF23
Autosomal Dominant Hypophosphatemic Rickets
Familial Tumoral Calcinosis with Hyperphosphatemia
Fibroblast Growth Factor 23
Oncogenic Osteomalacia
Phosphatonin
X-linked Hypophosphatemia
Intact-FGF23
Autosomal Dominant Hypophosphatemic Rickets
Familial Tumoral Calcinosis with Hyperphosphatemia
Fibroblast Growth Factor 23
Oncogenic Osteomalacia
Phosphatonin
X-linked Hypophosphatemia